Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside 
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings 
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle 
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement 
NEW YORK, May 01, 2018 -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it will be presenting at the 3rd annual Disruptive Growth & Healthcare Conference in New York City on Tuesday, May 8th at 1:45 PM, Eastern Time. Chief Executive Officer of NanoVibronix, Brian Murphy, will be presenting, as well as meeting with investors. Mr. Murphy will also be presenting on the Disruptive Pain Management Panel at 3:00 PM on May 8th.
The 2018 Disruptive Growth & Healthcare Conference will offer investors the opportunity to discover life science companies focusing on solutions for unmet medical needs and growth companies with disruptive technologies and business models.
About NanoVibronix
NanoVibronix Inc. (NASDAQ:NAOV) is a medical device company headquartered in Elmsford, NY with research and development in Nesher, Israel, that is focused on developing medical devices utilizing its proprietary and patented low intensity surface acoustic wave technology. The company's technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including the disruption of biofilms and bacteria colonization, as well as providing pain relief. The devices can be administered at home, without the assistance of medical professionals. The company's primary products include PainShield®, UroShield™ and WoundShield™. Additional information about the company is available at: www.nanovibronix.com.
About RHK Capital:
Advisory Group Equity Services, Ltd. (dba RHK Capital) was founded in 1984. RHK Capital is a boutique investment banking firm specializing in small to medium-sized transactions. RHK is led by a management team with extensive financial industry experience and a desire to provide companies and individuals with the tools and expertise to accomplish their financial goals. In addition to investment banking, RHK has grown to include businesses in general securities, emerging market securities, distressed and high yield debt securities, investment management, mortgages, and business lending. As a division of Advisory Group Equity Services (AGES), all securities are offered through Advisory Group Equity Services Ltd., a registered broker-dealer, member of the Financial Industry Regulatory Authority and the Securities Investor Protection Corporation.
Investor Contacts:
Crescendo Communications
[email protected]
(212) 671-1021
